Synovial fluid nitric oxide levels in patients with knee osteoarthritis

被引:106
作者
Karan, A [1 ]
Karan, MA [1 ]
Vural, P [1 ]
Erten, N [1 ]
Tasçioglu, C [1 ]
Aksoy, C [1 ]
Canbaz, M [1 ]
Öncel, A [1 ]
机构
[1] Istanbul Univ, TR-34390 Istanbul, Turkey
关键词
interleukin-1; beta; nitric oxide; osteoarthritis;
D O I
10.1007/s10067-003-0761-y
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Nitric oxide (NO) has an important role in the inflammatory arthropathies. This study investigated NO levels in the synovial fluid and plasma of patients with primary osteoarthritis (OA) of the knee. Twenty-seven cases with primary knee OA and 13 controls were recruited for the study. Nitrate/nitrite levels of synovial fluid and plasma were measured by Griess reaction, and interleukin-1beta (IL-1beta) levels were measured quantitatively by a sandwich immunoassay technique. We found a significant increase in the synovial fluid nitrate/nitrite levels in cases with primary OA of the knee compared to controls (50.26+/-23.63 mug/l vs 32.49+/-10.05 mug/l, p=0.002) as well as increased plasma nitrate/nitrite levels (57.06+/-23.32 mug/l vs 39.98+/-16.36 mug/l, p=0.012). There was no difference in plasma and synovial fluid IL-1beta concentrations between the study and control groups. These results may be considered as supporting evidence that NO might be one of the factors responsible for cartilage destruction in primary osteoarthritis of the knee.
引用
收藏
页码:397 / 399
页数:3
相关论文
共 23 条
[1]
Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society - Results from a workshop [J].
Altman, R ;
Brandt, K ;
Hochberg, M ;
MOskowitz, R ;
Bellamy, N ;
Bloch, DA ;
Buckwalter, J ;
Dougados, M ;
Ehrlich, G ;
Lequesne, M ;
Lohmander, S ;
Murphy, WA ;
RosarioJansen, T ;
Schwartz, B ;
Trippel, S .
OSTEOARTHRITIS AND CARTILAGE, 1996, 4 (04) :217-243
[2]
DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[3]
Amin Ashok R., 1999, Current Opinion in Rheumatology, V11, P202, DOI 10.1097/00002281-199905000-00009
[4]
Bauerová K, 1999, GEN PHYSIOL BIOPHYS, V18, P15
[5]
Nitric oxide modifies glycolytic pathways in cultured human synoviocytes [J].
Borderie, D ;
Le Marechal, H ;
Ekindjian, OG ;
Hernvann, A .
CELL BIOLOGY INTERNATIONAL, 2000, 24 (05) :285-289
[6]
INCREASED CONCENTRATIONS OF NITRITE IN SYNOVIAL-FLUID AND SERUM SAMPLES SUGGEST INCREASED NITRIC-OXIDE SYNTHESIS IN RHEUMATIC DISEASES [J].
FARRELL, AJ ;
BLAKE, DR ;
PALMER, RMJ ;
MONCADA, S .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (11) :1219-1222
[7]
Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO
[8]
2-9
[9]
GORDON GV, 1984, J RHEUMATOL, V11, P681
[10]
Grisham Matthew B., 1995, Methods (Orlando), V7, P84, DOI 10.1006/meth.1995.1012